Details of the Drug Reposition

General Information of This Drug (ID: DMQ8DWR)

Drug Name
Pivagabine   DMQ8DWR
Synonyms
4-Pivalamidobutanoic acid; 69542-93-4; 4-[(2,2-dimethylpropanoyl)amino]butanoic acid; UNII-C53SV0WO4V; Pivagabine [INN]; C53SV0WO4V; Pivagabine (INN); NCGC00160457-01; 4-(2,2-dimethylpropanamido)butanoic acid; 4-[(2,2-dimethylpropionyl)amino]butyric acid; DSSTox_CID_26162; DSSTox_RID_81393; DSSTox_GSID_46162; 4-(2,2-DIMETHYLPROPIONYLAMINO)BUTYRIC ACID; Tonerg; CAS-69542-93-4; 4-((2,2-Dimethylpropionyl)amino)butyric acid; SR-01000945179; CXB-722; EINECS 274-038-3; N-Trimethylacetyl-4-aminobutyric acid; CXB-722; CXB722
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Depression DIS3XJ69 6A70-6A7Z Phase 1 [1]
Anxiety disorder DISBI2BT 6B00-6B0Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00814931) Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males. U.S. National Institutes of Health.